Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 2B subunit alpha is one of five non-identical subunits (α, β, γ, δ, ε) of the eIF2B enzyme complex. eIF2B acts as a guanine nucleotide exchange factor (GEF), regenerating active GTP-bound eIF2 necessary for translation initiation. The alpha subunit is a key part of the regulatory core, modulating eIF2B’s response to cellular stress and phosphorylation signals. Its mutation or dysfunction impairs protein synthesis and can trigger severe neurological diseases such as vanishing white matter disease. The alpha subunit’s interaction with phosphorylated eIF2 alpha (eIF2α P) is central to cellular adaptive responses, making it a critical focal point in stress physiology and pathology.
Modulators of eIF2B activity generally target its guanine nucleotide exchange activity (GEF), affecting the cellular response to phosphorylation of eIF2 alpha and protein synthesis rates.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 2B subunit alpha (eIF2B alpha).